Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WR 242511

Known as: WR-242511, WR242511 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
IntroductionMany substances that form methemoglobin (MHb) effectively counter cyanide (CN) toxicity. Although MHb formers are… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 4
1997
1997
Various 4- and 8-aminoquinolines, which are effective antimalarial agents, were examined as potential pretreatment compounds for… Expand
1995
1995
The widely used 8-aminoquinoline antimalarial group of compounds and the derivatives such as WR242511 that are being developed… Expand
1994
1994
Malaria is a major cause of health problems in a large portion of the world. The 8-aminoquinoline compound, primaquine, is one of… Expand
1994
1994
Abstract : This study evaluated the toxicity of WR242511 Tartrate in rats following thirteen weeks of daily oral (gavage… Expand
1994
1994
Abstract : This dose range-finding study evaluated the developmental toxicity of WR242511 tartrate in time- mated New Zealand… Expand
1993
1993
The activities of 25 8-aminoquinolines were compared in tests assessing the ability of the compounds to inhibit the growth of… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
1993
1993
Primaquine and other 8-aminoquinolines are effective against Pneumocystis carinii in culture and animal models but the way(s) in… Expand
1993
1993
WR 242511 (or I) is a new compound of the 8-aminoquinoline class designed to replace primaquine for the treatment of malaria. In… Expand
1991
1991
Three 8-aminoquinolines from the Walter Reed Army Institute for Research (WRAIR), WR6026, WR238605, and WR242511, strongly… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4